Previous studies have demonstrated that NEK2 promotes drug resistance in multiple myeloma [41], it is very likely that enhanced aerobic glycolysis by NEK2 may contribute to its function in drug resistance. The gene discussed is NEK2; the disease is AL amyloidosis.